|
|
Higher dose statins reduce coronary artery plaque. |
 |
 |
|
AHA: High doses of two statins ? rosuvastatin (40 mg) and atorvastatin (80 mg) ? reversed the progression of coronary artery disease by reducing some of the plaque in clogged arteries supplying blood to the heart, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2011. The study is simultaneously published in the New England Journal of Medicine.
|
|
|
American Heart Association Scientific Sessions website. |
|
|
|
AHA: Science News from Scientific Sessions 2011 will be posted here beginning Saturday, Nov. 12, 2011 through Wednesday, Nov. 16, 2011. Please check back for frequent updates on late-breaking science during that time. Coverage will include: presentation slides and audio, discussant slides and audio, summary slides, PI video interviews, panel discussion videos, related links and articles, and more.
|
|
Niacin may not improve hard outcomes. |
|
|
|
University of Buffalo: At an 8 a.m. EST press conference today at the American Heart Association meeting, UB professor of medicine William E. Boden, MD, discusses the AIM-HIGH clinical trial, which found that niacin provides no incremental benefit to patients with atherosclerotic heart disease, whose levels of LDL cholesterol and non-HDL (which contributes to plaque in the arteries) were very well-controlled.
|
|
|
CETP inhibitor more than doubles HDL cholesterol levels. |
|
|
|
EurekAlert: Tuesday, Nov. 15, 2011, Cleveland, OH: Researchers at Cleveland Clinic reported today that administration of a new drug– evacetrapib – can dramatically increase HDL (good) cholesterol, while significantly lowering LDL (bad) cholesterol). At the highest tested dosage, the levels of HDL more than doubled.
|
|
Ain't necessarily so dept: Hypertrophic cardiomyopathy associated with long life. |
|
|
|
EurekAlert: Hypertrophic cardiomyopathy (HCM) is consistent with survival to normal life expectancy, including particularly advanced age into the tenth decade of life, with demise ultimately largely unrelated to this disease, according to a study being presented Nov. 13 at the American Heart Association (AHA) scientific sessions in Orlando, Fla.
|
|
|
|
|
<< Start < Prev 581 582 583 584 585 586 587 588 589 590 Next > End >>
|
|
Page 588 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
